Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • cornstalker_1944 cornstalker_1944 Nov 8, 2011 2:55 PM Flag

    are we dead money for now?

    good prospects, volume a tad low.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Catalysts:

      Q4 2011 commence Phase III endometriosis trials for Elagolix
      Q1 2012 Results of 14-day placebo controlled VMAT2 Phase II study
      Q1 Three month toxicology results VMAT2
      Q2 Initiate Phase IIb three-month tardive dyskinesia study in Schizophrenia patients
      Q2 Initiate Phase IIb three-month tardive dyskinesia study in bipolar and depression patients
      Q2 Initiate Phase IIb studies of VMAT2 inhibitor in a second indication (TBD)
      Q3/4 results of elagolix Uterine Fibroids Phase II study
      Q3/4 Completion of enrollment in endometriosis US Phase III program
      Q4 Results from Phase IIb three-month tardive dyskinesia in schizophrenia patients

 
NBIX
41.78-2.08(-4.74%)Jun 1 4:00 PMEDT